11/02/2021 - Institutional

Can Ruti focuses on the effect of COVID-19 in the gender perspective in biomedical research to celebrate the International Day of Women and Girls in Science

The 3^rd Celebration of the International Day of Women and Girls in Science at Can Ruti took place on Wednesday 10 February, organized by the multi-institutional working group "Women in Science (WiS)", and hosted by the IGTP. The symposium looked at data on the gender perspective of the effects of the Covid-19 pandemic presenting data from studies both on and off the campus and providing a platform for personal testimonies from men and women involved in research and healthcare.

08/02/2021 - Campus Can Ruti, Research

Blocking the spread of HIV or favouring the spread of the tuberculosis bacteria, the flip side of the Siglec-1 protein's absence

In 2016, the Retrovirology and Clinical Studies group at IrsiCaixa discovered how the absence of the Siglec-1 protein, involved in modulating the immune system, blocks the spread of HIV throughout the body. Now, a study led by the same research group and the Experimental Tuberculosis Unit of the Germans Trias i Pujol Research Institute (IGTP) has shown that, on the other hand, this same deficiency favours the dissemination of Mycobacterium tuberculosis (Mtb), the tuberculosis-causing agent. 

29/01/2021 - Research

The CMCiB contributes to a new e-book on researcher and animal safety

A new e-book published by the Journal Laboratory Equipment, called Safe and Effective Research in the Vivarium features a case study from the Centre for Comparative Medicine and Bioimage of the IGTP (CMCiB-IGTP). Staff from the CMCiB have provided expert advice on aspects of safety.

28/01/2021 - Research

A pilot study reveals that natural killer cells could track the progress of type 1 diabetes

The Immunology of Diabetes Group, led by Marta Vives-PI has shown that levels of 4 subtypes of natural killer (NK) cells in the blood of Type 1 Diabetes patients change through different stages of the disease. These cells have a complex role in the immune attack during T1D and have been implicated in both the destruction and protection of insulin-producing cells. This pilot study, published in Frontiers in Immunology, tracks the levels of 4 subtypes of NK cells and suggests that these cells are good candidate biomarkers for disease progression.

13/01/2021 - Campus Can Ruti, Projects

8 health professionals from Germans Trias awarded Talents grants

The Talents Programme supports research projects in the health sector and despite the pandemic research into other diseases continues. 14 health professionals in all, and 8 of them from Germans Trias i Pujol, have been awarded grants to carry out research projects in the 2020 edition of the programme. The awards represent recognition for young health professionals who are carrying out research activities.

16/12/2020 - Amics deCan Ruti

ECOMASC collects 6,250 euros for COVID-19 research at the IGTP

ECOMASC (Eco-masks) is playing its part in the battle against COVID-19. On 9 December the Moda Dstil shops of Catalonia presented a cheque for 6,250 euros to the Germans Trias I Pujol Research Institute (IGTP). ECOMASC has not only helped to prevent the propagation of the virus with its masks, but it has also made a generous gesture so that research can continue to look for solutions to COVID-19.

11/12/2020 - Innovation, Research

Two IGTP spin-off companies receive the European Commission’s Seal of Excellence

Two spin-off companies of the Germans Trias I Pujol Research Institute (IGTP) Biointaxis and Time is Brain have received the Seal of Excellence from the European Commission. The two companies with IGTP participation have opted for financing from the Horizon 2020 Programme and the award puts them in an advantageous position when requesting funds from other funding bodies.

11/12/2020 - Research

An interactomic study identifies a protein as a possible new therapeutic target to prevent neurodegeneration after stroke

A group of researchers led from the Germans Trias i Pujol Institute have conducted an in-depth in-vitro study into the DAPK1 interactome during stroke conditions. They have identified the proteins in the DAPK1 interactome and singled out LRRFIP1 as a possible therapeutic target for neuroprotection after stroke. The study is published in Antioxidants.

10/12/2020 - Research

Two studies show the way ahead for better non-invasive monitoring of kidney transplants

Members of the Kidney-affecting Diseases Research Group and the Innovation in Vesicles and Cells for Application in Therapy (REMAR-IVECAT) have recently published two studies led by Dr Francesc E. Borràs, which identify possible biomarkers of irreversible damage to transplanted kidneys; a pathology that eventually causes them to stop working. The papers have been published in the International Journal of Molecular Science and the Journal of Nephrology.

27/11/2020 - Research

The IGTP Participates in 3 Projects funded by the 2019 Edition of La Marató

The Germans Trias i Pujol Research Institute (IGTP) has received a total of 305,680 euros for three projects on rare diseases in which it participates or coordinates. In total the three projects have received financing of more than a million euros, to be divided between the several institutions participating. This edition of the fundraising marathon will fund a total of 41 biomedical research projects of excellence on rare diseases. The projects aim to provide better diagnosis at birth and provide more efficient and safer treatments to improve quality of life and extend the lifespans of people affected.